ID   RYK_HUMAN               Reviewed;         604 AA.
AC   P34925; Q04696;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   05-OCT-2010, entry version 108.
DE   RecName: Full=Tyrosine-protein kinase RYK;
DE            EC=2.7.10.1;
DE   Flags: Precursor;
GN   Name=RYK; Synonyms=JTK5A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=93241737; PubMed=8386829;
RA   Stacker S.A., Hovens C.M., Vitali A., Pritchard M.A., Baker E.,
RA   Sutherland G.R., Wilks A.F.;
RT   "Molecular cloning and chromosomal localisation of the human homologue
RT   of a receptor related to tyrosine kinases (RYK).";
RL   Oncogene 8:1347-1356(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   MEDLINE=93288416; PubMed=8390040;
RA   Tamagnone L., Partanen J., Armstrong E., Lasota J., Ohgami K.,
RA   Tazunoki T., Laforgia S., Huebner K., Alitalo K.;
RT   "The human ryk cDNA sequence predicts a protein containing two
RT   putative transmembrane segments and a tyrosine kinase catalytic
RT   domain.";
RL   Oncogene 8:2009-2014(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 28-604 (ISOFORM 1).
RC   TISSUE=Ovary;
RX   MEDLINE=96295014; PubMed=8726462;
RA   Wang X.C., Katso R., Butler R., Hanby A.M., Poulsom R., Jones T.,
RA   Sheer D., Ganesan T.S.;
RT   "H-RYK, an unusual receptor kinase: isolation and analysis of
RT   expression in ovarian cancer.";
RL   Mol. Med. 2:189-203(1996).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-96; CYS-224 AND ILE-240.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Potential growth factor receptor protein tyrosine
CC       kinase.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein (Potential).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P34925-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P34925-2; Sequence=VSP_005009;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Observed in all the tissues examined.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 WIF domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S59184; AAB26341.1; -; mRNA.
DR   EMBL; X69970; CAA49591.1; -; mRNA.
DR   EMBL; X96588; CAA65406.1; -; mRNA.
DR   IPI; IPI00219225; -.
DR   IPI; IPI00298345; -.
DR   PIR; I37560; I37560.
DR   RefSeq; NP_001005861.1; -.
DR   RefSeq; NP_002949.2; -.
DR   UniGene; Hs.654562; -.
DR   ProteinModelPortal; P34925; -.
DR   SMR; P34925; 58-196, 294-591, 320-600.
DR   STRING; P34925; -.
DR   PRIDE; P34925; -.
DR   Ensembl; ENST00000296084; ENSP00000296084; ENSG00000163785.
DR   GeneID; 6259; -.
DR   KEGG; hsa:6259; -.
DR   CTD; 6259; -.
DR   GeneCards; GC03M133794; -.
DR   H-InvDB; HIX0030806; -.
DR   HGNC; HGNC:10481; RYK.
DR   MIM; 600524; gene.
DR   PharmGKB; PA34894; -.
DR   eggNOG; prNOG05836; -.
DR   HOGENOM; HBG314284; -.
DR   HOVERGEN; HBG047417; -.
DR   InParanoid; P34925; -.
DR   BRENDA; 2.7.10.1; 247.
DR   NextBio; 24309; -.
DR   ArrayExpress; P34925; -.
DR   Bgee; P34925; -.
DR   CleanEx; HS_RYK; -.
DR   Genevestigator; P34925; -.
DR   GermOnline; ENSG00000163785; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; NAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020740; Tyr_prot_kinase_rcpt_RYK.
DR   InterPro; IPR003306; WIF.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF251; Tyr_prot_kinase_rcpt_RYK; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF02019; WIF; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   ProDom; PD013948; WIF; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SMART; SM00469; WIF; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50814; WIF; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Complete proteome; Glycoprotein;
KW   Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     25       Potential.
FT   CHAIN        26    604       Tyrosine-protein kinase RYK.
FT                                /FTId=PRO_0000024464.
FT   TOPO_DOM     26    224       Extracellular (Potential).
FT   TRANSMEM    225    252       Helical; (Potential).
FT   TOPO_DOM    253    604       Cytoplasmic (Potential).
FT   DOMAIN       63    191       WIF.
FT   DOMAIN      327    600       Protein kinase.
FT   NP_BIND     333    341       ATP (By similarity).
FT   ACT_SITE    462    462       Proton acceptor (By similarity).
FT   BINDING     361    361       ATP (By similarity).
FT   MOD_RES     492    492       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD    136    136       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    171    171       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    175    175       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    179    179       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    206    206       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ     294    294       S -> SSLG (in isoform 2).
FT                                /FTId=VSP_005009.
FT   VARIANT      96     96       N -> S.
FT                                /FTId=VAR_041800.
FT   VARIANT     224    224       R -> C.
FT                                /FTId=VAR_041801.
FT   VARIANT     240    240       V -> I (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041802.
FT   CONFLICT     18     46       PALRAAAAPALLLARCAVAAAAGLRAAAR -> RGLRAPPP
FT                                PPLLLLLALLPLLPAPGAAAAPA (in Ref. 2).
FT   CONFLICT    251    251       N -> S (in Ref. 2; CAA49591).
FT   CONFLICT    316    316       K -> E (in Ref. 2; CAA49591).
FT   CONFLICT    355    355       E -> K (in Ref. 3).
FT   CONFLICT    437    437       Q -> H (in Ref. 2; CAA49591).
FT   CONFLICT    443    443       A -> P (in Ref. 2; CAA49591).
FT   CONFLICT    528    528       T -> NS (in Ref. 1; AAB26341).
FT   CONFLICT    541    541       V -> TL (in Ref. 1; AAB26341).
FT   CONFLICT    563    563       N -> T (in Ref. 1; AAB26341).
FT   CONFLICT    585    585       K -> R (in Ref. 1; AAB26341).
SQ   SEQUENCE   604 AA;  67507 MW;  06D59C0FEAB63397 CRC64;
     MRGAARLGRP GRSCLPGPAL RAAAAPALLL ARCAVAAAAG LRAAARPRPP ELQSASAGPS
     VSLYLSEDEV RRLIGLDAEL YYVRNDLISH YALSFNLLVP SETNFLHFTW HAKSKVEYKL
     GFQVDNVLAM DMPQVNISVQ GEVPRTLSVF RVELSCTGKV DSEVMILMQL NLTVNSSKNF
     TVLNFKRRKM CYKKLEEVKT SALDKNTSRT IYDPVHAAPT TSTRVFYISV GVCCAVIFLV
     AIILAVLHLH NMKRIELDDS ISASSSSQGL SQPSTQTTQY LRADTPNNAT PITSYPTLRI
     EKNDLRSVTL LEAKGKVKDI AISRERITLK DVLQEGTFGR IFHGILIDEK DPNKEKQAFV
     KTVKDQASEI QVTMMLTESC KLRGLHHRNL LPITHVCIEE GEKPMVILPY MNWGNLKLFL
     RQCKLVEANN PQAISQQDLV HMAIQIACGM SYLARREVIH KDLAARNCVI DDTLQVKITD
     NALSRDLFPM DYHCLGDNEN RPVRWMALES LVNNEFSSAS DVWAFGVTLW ELMTLGQTPY
     VDIDPFEMAA YLKDGYRIAQ PINCPDELFA VMACCWALDP EERPKFQQLV QCLTEFHAAL
     GAYV
//
